Classified as an investigational new drug, available only within clinical trials Not approved for medical use in humans outside of research protocols Cannot be legally prescribed, dispensed, or marketed for therapeutic purposes Federal law explicitly prohibits use in compounded medications under sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act WADA Prohibition Status Based on WADAs prohibition categories: GLP3 likely falls under Section S0 (Non-Approved Substances) of the WADA Prohibited List, which includes: Any pharmacological substance not approved by governmental regulatory health authorities for human therapeutic use Drugs under preclinical or clinical development Substances without current regulatory approval from any health authority worldwide Implications for competitive athletes: Prohibited at all times (in-competition and out-of-competition) No Therapeutic Use Exemptions available for unapproved substances Use could result in anti-doping rule violations and sanctions Detection methods under development as clinical trials progress Research Classification: GLP3 is not intended for commercial sale, medical use outside research protocols, veterinary applications, or dietary supplement formulations

Persistent dry mouth, bleeding gums, mouth sores, tooth sensitivity, bad breath, or changes in denture fit should be reported to a dentist
For perimenopausal readers specifically, our GLP-1 menopause weight loss breakdown covers why HRT integration changes the equation
Depending on the injection, it might include other B vitamins
You May Have Higher Muscle Glycogen Storage Studies report that taking creatine with carbohydrate and protein supplements can enhance muscle glycogen storage compared to just supplementing with carbohydrates alone
Do not quit